These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 9130721)

  • 1. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
    Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
    EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulated splicing of an alternative exon of beta-tropomyosin pre-mRNAs in myogenic cells depends on the strength of pyrimidine-rich intronic enhancer elements.
    Pret AM; Balvay L; Fiszman MY
    DNA Cell Biol; 1999 Sep; 18(9):671-83. PubMed ID: 10492398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific splicing of two mutually exclusive exons of the chicken beta-tropomyosin pre-mRNA: positive and negative regulations.
    Gallego ME; Sirand-Pugnet P; Durosay P; Clouet d'Orval B; d'Aubenton-Carafa Y; Brody E; Expert-Bezançon A; Marie J
    Biochimie; 1996; 78(6):457-65. PubMed ID: 8915535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken beta-tropomyosin pre-mRNA.
    Expert-Bezançon A; Le Caer JP; Marie J
    J Biol Chem; 2002 May; 277(19):16614-23. PubMed ID: 11867641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cis regulating elements which control in vivo alternative splicing of the chicken beta tropomyosin primary transcript.
    Fiszman MY; Libri D; Balvay L
    Symp Soc Exp Biol; 1992; 46():355-62. PubMed ID: 1341048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon.
    Gooding C; Roberts GC; Smith CW
    RNA; 1998 Jan; 4(1):85-100. PubMed ID: 9436911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-acting sequences involved in exon selection in the chicken beta-tropomyosin gene.
    Gallego ME; Balvay L; Brody E
    Mol Cell Biol; 1992 Dec; 12(12):5415-25. PubMed ID: 1280322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
    Cao W; Jamison SF; Garcia-Blanco MA
    RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
    Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
    J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence divergence associated with species-specific splicing of the nonmuscle beta-tropomyosin alternative exon.
    Pret AM; Fiszman MY
    J Biol Chem; 1996 May; 271(19):11511-7. PubMed ID: 8626711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
    Jumaa H; Nielsen PJ
    EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.
    Liu HX; Chew SL; Cartegni L; Zhang MQ; Krainer AR
    Mol Cell Biol; 2000 Feb; 20(3):1063-71. PubMed ID: 10629063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASF/SF2 and SC35 regulate the glutamate receptor subunit 2 alternative flip/flop splicing.
    Crovato TE; Egebjerg J
    FEBS Lett; 2005 Aug; 579(19):4138-44. PubMed ID: 16023113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
    Liao HJ; Baker CC; Princler GL; Derse D
    Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
    Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
    J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.